Curcumin induces apoptotic cell death via Oct4 inhibition and GSK-3β activation in NCCIT cells

Overexpression of Oct4 suppresses the metastatic potential of breast cancer cells via Rnd1 downregulation

(2014) Long Shen et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Transcription factor OCT4 promotes cell cycle progression by regulating CCND1 expression in esophageal carcinoma

(2014) Zhigang Li et al.   CANCER LETTERS

Comparative absorption of curcumin formulations

(2014) Ralf Jäger et al.   Nutrition Journal

Knockdown of Oct4 and Nanog expression inhibits the stemness of pancreatic cancer cells

(2013) Yuhua Lu et al.   CANCER LETTERS

Oct-4 is required for an antiapoptotic behavior of chemoresistant colorectal cancer cells enriched for cancer stem cells: Effects associated with STAT3/Survivin

(2013) Kunming Wen et al.   CANCER LETTERS

Bifunctional Chemopreventive Effects of Adenocaulon himalaicum Through Induction of Detoxification Enzymes and Apoptosis

(2013) Ji Ho Yun et al.   JOURNAL OF MEDICINAL FOOD

The role of cancer stem cells in the anti-carcinogenicity of curcumin

(2013) Leonie Norris et al.   MOLECULAR NUTRITION & FOOD RESEARCH

OCT4 promotes tumorigenesis and inhibits apoptosis of cervical cancer cells by miR-125b/BAK1 pathway

(2013) Y-D Wang et al.   Cell Death & Disease

Nuclear factor-E2 (Nrf2) is regulated through the differential activation of ERK1/2 and PKC α/βII by Gymnasterkoreayne B

(2012) Kyung-Mi Lee et al.   CANCER LETTERS

The Targets of Curcumin

(2012) Hongyu Zhou et al.   CURRENT DRUG TARGETS

Attributes of Oct4 in stem cell biology: perspectives on cancer stem cells of the ovary

(2012) Chantel Samardzija et al.   Journal of Ovarian Research

Downregulation of transcription factor Oct4 induces an epithelial-to-mesenchymal transition via enhancement of Ca2+ influx in breast cancer cells

(2011) Jiajia Hu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

β-Catenin Enhances Oct-4 Activity and Reinforces Pluripotency through a TCF-Independent Mechanism

(2011) Kevin F. Kelly et al.   Cell Stem Cell

Curcumin nanoformulations: a future nanomedicine for cancer

(2011) Murali M. Yallapu et al.   DRUG DISCOVERY TODAY

Oct4 was a novel target of Wnt signaling pathway

(2011) Jun Li et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Targeting cancer stem cells by inhibiting Wnt, Notch and Hedgehog pathways

(2010) Naoko Takebe et al.   Nature Reviews Clinical Oncology

Tectoridin, a poor ligand of estrogen receptor α, exerts its estrogenic effects via an ERK-dependent pathway

(2009) Kyungsu Kang et al.   MOLECULES AND CELLS

Tumour-initiating cells: challenges and opportunities for anticancer drug discovery

(2009) Bin-Bing S. Zhou et al.   NATURE REVIEWS DRUG DISCOVERY

Induction of the Phase II Detoxification Enzyme NQO1 in Hepatocarcinoma Cells by Lignans from the Fruit ofSchisandra chinensisthrough Nuclear Accumulation of Nrf2

(2009) Saet Lee et al.   PLANTA MEDICA

Octamer 4 Small Interfering RNA Results in Cancer Stem Cell-Like Cell Apoptosis

(2008) T. Hu et al.   CANCER RESEARCH

Cutaneous cancer stem cell maintenance is dependent on β-catenin signalling

(2008) Ilaria Malanchi et al.   NATURE

Oct-4 Is Critical for Survival/Antiapoptosis of Murine Embryonic Stem Cells Subjected to Stress: Effects Associated with Stat3/Survivin

(2007) Ying Guo et al.   STEM CELLS